ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Institutional Ownership and Insiders Activity
No institutional investors currently report ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
Institutional Holders
0
Total Reported Value
$0
Largest Holder
—
Largest Position
—
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
0
Funds Exiting Positions
9
Top Institutional Owners
View allNo holder data available.
Related ADAP Institutional Insights:
- ADAP 13F Institutional Holders
- ADAP Top Institutional Shareholders
- ADAP Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ADAP Insider Trading & SEC Form 4 Activity
- ADAP Articles
- Top Institutional Investor Stock Rankings